Evidence map›Paper›PMID 36123452›Full record

ArticleAnnals of hematology2022

Clinical and prognostic role of 2-[

Xiaoyue Tan, Hui Yuan, Dongjiang Li, Xiaolin Sun, Chongyang Ding, Lei Jiang

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of hematology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Vasculature cast sign onEuropean journal of nuclear medicine and molecular imaging · 2026
    Article
  4. Article
  5. Article
  6. Semiquantitative 2-[Frontiers in medicine · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Xiaoyue Tan *PET Center, Department of Nuclear Medicine, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou, 510080, China.
Hui Yuan *PET Center, Department of Nuclear Medicine, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou, 510080, China.
Dongjiang LiPET Center, Department of Nuclear Medicine, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou, 510080, China.
Xiaolin SunPET Center, Department of Nuclear Medicine, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou, 510080, China.
Chongyang DingDepartment of Nuclear Medicine, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Rd, Nanjing, 210029, China. chongyangding@163.com.
Lei JiangPET Center, Department of Nuclear Medicine, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou, 510080, China. leijiang1031@163.com.ORCID http://orcid.org/0000-0002-9479-132X
Guangdong Academy of Medical Sciences · CNJiangsu Province Hospital · CN

Funding

Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application No. 2022B1212010011Guangdong Provincial People's Hospital KY0120211130National Natural Science Foundation of China 81971645
6 · The paper itself

Abstract

T-cell lymphoblastic lymphoma (T-LBL) is a rare and highly aggressive non-Hodgkin lymphoma. This study aimed to explore the role of 2-[

Indexed as

Lymphoma, T-CellPrecursor Cell Lymphoblastic Leukemia-LymphomaAdultChildFemaleFluorodeoxyglucose F18HumansMalePositron Emission Tomography Computed TomographyPrognosisRadiopharmaceuticalsRetrospective StudiesT-LymphocytesTumor BurdenFluorodeoxyglucose F18Radiopharmaceuticals2-[18F]FDG PET/CTMetabolic parametersPrognosisSarcopeniaT-cell lymphoblastic lymphoma (T-LBL)

Identifiers

PMID36123452
OpenAlexW4296460800

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.